François Danion

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 293 citations · Full text

Is COVID-19 infection more severe in kidney transplant recipients?

Sophie Caillard, Nathalie Chavarot, H. François et al. · American Journal of Transplantation · 2020 · 259 citations · Full text

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

George R. Thompson, Àlex Soriano, Oliver A. Cornely et al. · The Lancet · 2022 · 150 citations · Full text

Translational Medicine, Antifungal Agent, Antifungal Agents +6

Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

Martin Hoenigl, Jon Salmanton‐García, Matthias Egger et al. · The Lancet Infectious Diseases · 2023 · 125 citations · Full text

Preventive Medicine, Guideline Adherence, Treatment And Prevention +5